Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Nephrology
•
Glomerulonephritis
What is your treatment approach for patients with crescentic IgA nephropathy who fail to respond to cyclophosphamide and steroids?
Related Questions
Do you ever combine voclosporin and belimumab in the treatment of lupus nephritis?
What is your approach to the management of secondary membranous nephropathy with nephrotic range proteinuria?
Would you recommend genetic testing to determine if there is a potential underlying primary process in a patient with congenital solitary kidney who is presumed to have secondary FSGS?
What are some measures to prevent flares of loin pain-hematuria syndrome?
Do you prefer a mycophenolate or tacrolimus based glucocorticoid-sparing regimen for patients with minimal change disease?
Do you routinely obtain serum anti-THSD7A and anti-NELL1 tests in your patients with nephrotic syndrome suspected secondary to membraneous nephropathy?
What are your management strategies for patients with biopsy proven IgA nephropathy with rapidly progressive glomerulonephritis?
What drives you to choose voclospsorin over tacrolimus given the substantially higher cost?
In which patients with suspected IgA nephropathy and microalbuminuria would you recommend a kidney biopsy?
How do you approach treatment for patients with proliferative glomerulonephritis with monoclonal IgG deposits (PGNMID) with end-stage renal disease who are considering kidney transplant?
